MAPK3 and pancreatic neoplasm: The intensity and duration of ERK1/2 activation seems also to influence autophagy, as for example its prolonged activation has been reported to reduce the autophagic flux26 while, in pancreatic cancer, ERK1/2 inhibition de‐regulated metabolic activity and promoted autophagy.42